Login

Fresh Off an $120 Million IPO, Werewolf Therapeutics Expands Into Watertown, Massachusetts

Biotech Company Leases Space in Alexandria's Arsenal on the Charles Complex
200 Talcott Ave., also known as Building 37 in the Arsenal on the Charles. (CoStar)
200 Talcott Ave., also known as Building 37 in the Arsenal on the Charles. (CoStar)
By Regin Johnson
CoStar Research
June 8, 2021 | 6:37 P.M.

Werewolf Therapeutics, a Boston-based biopharmaceutical company with the clever ticker symbol HOWL following its $120 million initial public offering this spring, is expanding by leasing addition office-lab space from Alexandria Real Estate Equities in Watertown, Massachusetts.

This news story is available exclusively to CoStar subscribers.

Watch the video to learn how you can access industry leading CRE news and the data analytics you need to drive success.

This news story is available exclusively to CoStar subscribers.

Ready to Learn More?

Sign Up For a Personalized Demo.

Sign Up For a Demo To Learn More.

Already A Subscriber? Sign In

IN THIS ARTICLE